Immunosyn news from FierceBiotech
NewsC&L: Valeant makes management changes
Valeant Pharmaceuticals International has appointed J. Michael Pearson to the position of chief executive officer following the resignation of Timothy Tyson as president, chief executive officer and Read more...
| Press ReleasesPRESS RELEASE: Immunosyn Corporation Names Stephen Ferrone as CEO Immunosyn Corporation Names Stephen Ferrone as CEO LA JOLLA, Calif., Oct. 23 -- Immunosyn Corporation has announced the appointment of Stephen D. Ferrone as the company's Chief Executive Officer, Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets